Amtagvi Approval Boosted Iovance Biotherapeutics, Inc. (IOVA), But Can the Rally Last?
- Published
- Source
- YahooFinance
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) has seen its stock price rise following the conditional approval of its melanoma treatment, Amtagvi, by the Therapeutic Goods Administration of Australia on June 4, 2026. This approval marks a significant milestone as it is the third marketing authorization for Amtagvi, which is crucial in a country with the highest melanoma rates globally. Despite the initial surge in stock value, IOVA's shares have returned to pre-approval levels, reflecting market volatility. Analysts remain optimistic, with 80% expressing a bullish outlook on the company, although Chardan recently adjusted its price target from $16 to $14, citing revised revenue forecasts. Management anticipates Q2 revenue from Amtagvi to be between $79 million and $81 million. Founded in 2007 and based in California, Iovance specializes in cell therapies for metastatic melanoma and other solid tumors. While the company shows promise as an investment, some analysts suggest that certain AI stocks may present greater potential for returns with less risk.
Original report
Amtagvi Approval Boosted Iovance Biotherapeutics, Inc. (IOVA), But Can the Rally Last?
YahooFinanceThis briefing is an independently written summary based on publicly available reporting and is provided for industry information and news discovery. The original report and source publication are credited and linked where applicable. RobotToday does not claim ownership of third-party source material.
Rights concerns? Contact [email protected] with the relevant URL and details. We will review the matter and take appropriate action where warranted.
More related news
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
Related Suppliers
Aiyuwencheng 江苏艾雨文承养老机器人有限公司
China
Chinese eldercare robot maker behind 'Datou A Liang', China's first home-based companion robot for seniors with active patrol and sleep monitoring.
Blue Frog Robotics
France
French social robotics company developing Buddy, an emotional AI companion robot for education, eldercare, inclusion, and hospitality.
Bodyfriend 바디프랜드
Korea, Republic of (South)
Seoul-based massage and wellness chair maker founded 2007; builds the Falcon, Familie, and 733 chair lines using its patented ROVO bipedal leg-massage system.
BioRobotics Laboratory, Korea University of Technology and Education
Korea, Republic of (South)
South Korean university research laboratory focusing on haptics, exoskeletons, rehabilitation robotics, and autonomous ground vehicles.
McMaster Manufacturing Research Institute
Canada
Hamilton, Ontario applied manufacturing research center at McMaster University; runs a 21,000 sq ft facility with seven research labs.
Robotics Education & Competition Foundation
United States
The REC Foundation is a US nonprofit that runs VEX-based robotics and drone competitions reaching 1.1 million students across 70 countries.
Robotics needs a service framework.
RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
Join the RobotToday community on LinkedIn
Daily robotics news, in-depth analysis, conference highlights, and discussions with professionals worldwide.
